Abstract:Background Polo-like kinase 1 (PLK1) is highly expressed in many human cancers and regulates critical steps in mitotic progression. Previously, we have reported that PLK1 was overexpressed in non-small cell lung cancer (NSCLC), but the underlying molecular mechanisms are not well understood. By using microRNA (miR) target prediction algorithms, we identified miR-100 that might potentially bind the 3’-untranslated region of PLK1 transcripts. The purpose of this study was to investigate the roles of miR-100 and its association with PLK1 in NSCLC development. Methods Taqman real-time quantitative RT-PCR assay was performed to detect miR-100 expression 10 NSCLC tissues and corresponding nontumor tissues. Additionally, the expression of miR-100 in 110 NSCLC tissues and its correlation with clinicopathological factors or prognosis of patients was analyzed. Finally, the effects of miR-100 expression on growth, apoptosis and cell cycle of NSCLC cells by posttranscriptionally regulating PLK1 expression were determined. Results MiR-100 was significantly downregulated in NSCLC tissues, and low miR-100 expression was found to be closely correlated with higher clinical stage, advanced tumor classification and lymph node metastasis of patients. The overall survival of NSCLC patients with low miR-100 was significantly lower than that of those patients with high miR-100, and univariate and multivariate analyses indicated that low miR-100 expression might be a poor prognostic factor. Also, miR-100 mimics could lead to growth inhibition, G 2 /M cell cycle arrest and apoptosis enhancement in NSCLC cells. Meanwhile, miR-100 mimics could significantly inhibit PLK1 mRNA and protein expression and reduce the luciferase activity of a PLK1 3’ untranslated region-based reporter construct in A549 cells. Furthermore, small interfering RNA (siRNA)-mediated PLK1 downregulation could mimic the effects of miR-100 mimics while PLK1 overexpression could partially rescue the phenotypical changes of NSCLC cells induced by miR-100 mimics. Conclusions Our findings indicate that low miR-100 may be a poor prognostic factor for NSCLC patients and functions as a tumor suppressor by posttranscriptionally regulating PLK1 expression.

Potential role of miR-100 in cancer diagnosis, prognosis, and therapy

Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential.

Multiple Roles of MicroRNA-100 in Human Cancer and Its Therapeutic Potential

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

The Potential Role of miR-451 in Cancer Diagnosis, Prognosis, and Therapy

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

Potential Role of Mir-139-5p in Cancer Diagnosis, Prognosis and Therapy

Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.

Reduced Mir-100 Expression in Cervical Cancer and Precursors and Its Carcinogenic Effect Through Targeting PLK1 Protein.

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer

Mir-30D-5p: A Non-Coding RNA with Potential Diagnostic, Prognostic and Therapeutic Applications

Prognostic role of microRNA-100 in various carcinomas: evidence from six studies

MicroRNA-100 is a Potential Molecular Marker of Non-Small Cell Lung Cancer and Functions As a Tumor Suppressor by Targeting Polo-Like Kinase 1

Application of MicroRNA in Cancer Diagnosis and Therapy

miRNA-based biomarkers, therapies, and resistance in Cancer

microRNA:A new cancer biomarker

MicroRNA-100 Regulates Pancreatic Cancer Cells Growth and Sensitivity to Chemotherapy Through Targeting FGFR3.

Reduced Expression of Microrna-100 Confers Unfavorable Prognosis in Patients with Bladder Cancer

Potential Microrna Targets For Cancer Chemotherapy

MiRNAs and Cancer: Key Link in Diagnosis and Therapy